Imanis Life Sciences

Menu

Dueling quantitative COVID-19 neutralizing antibody tests roll out as vaccines approach completion

As COVID-19 vaccines ready themselves for market, two companies have turned their attention to what comes next – verifying whether the vaccines provide effective and lasting protection against SARS-CoV-2.

November 19, 2020, Imanis Life Sciences, Rochester MN

As COVID-19 vaccines ready themselves for market, two companies have turned their attention to what comes next – verifying whether the vaccines provide effective and lasting protection against SARS-CoV-2. Imanis Life Sciences and Siemens Healthineers have both announced the development of their scalable quantitative neutralizing antibody assays, a noteworthy advancement from the +/- results yielded by widely used antibody tests.

With a quantitative test result, physicians and researchers can track neutralizing antibody titers over time to better understand the short- and long-term efficacy of COVID-19 vaccines.

Published November 19, 2020: https://www.bioworld.com/articles/500422-dueling-quantitative-covid-19-neutralizing-antibody-tests-roll-out-as-vaccines-approach-completion

Learning Resources

Stay Informed

Stay up to date on the latest from the Imanis team, including product releases, promotional codes, and exciting new advancements in noninvasive in vivo imaging!